STXBP1 and SYNGAP1 natural history study
Part of Genetic & congenital clinical trials.
This study follows people with STXBP1 or SYNGAP1 gene changes over time to learn more about how these conditions affect the body and mind. It does not test a treatment but helps researchers understand the natural course of the disorder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) have a confirmed change in the STXBP1 or SYNGAP1 gene that causes the disorder.
- You can be any age, male or female.
- You cannot have a major brain injury, stroke, or serious heart problem from birth.
- You cannot have a mutation in another gene that clearly causes a different brain disorder.
- If you are a female of childbearing age, you must not be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with a confirmed STXBP1 genetic change to help prepare for future clinical trials. It collects information about the condition to better understand it.
This study looks at children with a confirmed STXBP1 genetic mutation to better understand the condition and find biological markers. It aims to help diagnose and treat the disease more effectively in the future.
This early-phase study tests how safe ETX101 is and whether it can help reduce seizures in young children with Dravet syndrome caused by an SCN1A gene change. It mainly enrolls infants and children with a specific type of seizure history and genetic result.
This study uses advanced genetic tests to find the cause of severe intellectual disability or related developmental disorders when standard tests found nothing. If you or your child qualify, the study may provide a clearer diagnosis and help guide care.
This trial tests a one-time gene therapy (BFB-101) for children with SPG47, a genetic condition that affects movement and brain function. The therapy aims to deliver a working copy of the AP4B1 gene to help slow or stop the disease's progression.
This study follows children with Dravet syndrome caused by a specific SCN1A gene change to understand how the condition develops over time. It may help families know more about what to expect.
Hear when a new Genetic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.